Ignite Creation Date:
2024-05-06 @ 6:22 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05639933
Status:
RECRUITING
Last Update Posted:
2024-02-14
First Post:
2022-11-14
Brief Title:
Study to Investigate the Efficacy Safety and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
Sponsor:
Hoth Therapeutics Inc
Organization:
Hoth Therapeutics Inc
Organization Data
Organization:
Hoth Therapeutics Inc
Class:
OTHER
Study ID:
CLEER-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hoth Therapeutics Inc
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Worldwide Clinical Trials | OTHER |